(Reuters) – Drugmaker Pfizer Inc is thinking approximately selling hospital products maker Hospira's infusion pump business for approximately $2 billion, Bloomberg reported, citing people familiar with the matter.
Talks are said to be at an early stage, Bloomberg reported on Wednesday. (http://bloom.bg/1OQhp8A)
Pfizer closed its $15 billion acquisition of Hospira, which makes biosimilars & generic versions of injectable drugs, in September.
p> A Pfizer spokeswoman declined to comment.
Infusion pumps are computerized & are designed to deliver medications directly into patients' bloodstreams.
In November, Pfizer said it would buy Botox maker Allergan Plc in a deal worth $160 billion, which would create the world's largest drugmaker.
(Reporting by Anya George Tharakan in Bengaluru; Editing by Sunil Nair)
Health Care IndustryMergers, Acquisitions & TakeoversHospiraBloomberginfusion pumpPfizer Inc